Eman K. A. Abdelall, Heba A. H. Elshemy, Madlen B. Labib & Fatma E. A. Mohamed. (2023) Design, synthesis of novel chromene‐based scaffolds targeting hepatocellular carcinoma: Cell cycle arrest, cytotoxic effect against resistant cancer cells, apoptosis induction, and c‐Src inhibition. Drug Development Research.
Crossref
Ming-Ming Hu & Hong-Bing Shu. (2023) Mitochondrial DNA-triggered innate immune response: mechanisms and diseases. Cellular & Molecular Immunology 20:12, pages 1403-1412.
Crossref
Saverio Marchi, Emma Guilbaud, Stephen W. G. Tait, Takahiro Yamazaki & Lorenzo Galluzzi. (2022) Mitochondrial control of inflammation. Nature Reviews Immunology 23:3, pages 159-173.
Crossref
Giulia Petroni, Aitziber Buqué, Lisa M. Coussens & Lorenzo Galluzzi. (2022) Targeting oncogene and non-oncogene addiction to inflame the tumour microenvironment. Nature Reviews Drug Discovery 21:6, pages 440-462.
Crossref
Claudia Galassi, Yangjingyi Ruan, Ai Sato, Carlos Jiménez-Cortegana, Vanessa Klapp, Norma Bloy, Emma Guilbaud, Giulia Petroni, Aitziber Buqué, Lorenzo Galluzzi & Takahiro Yamazaki. 2022. Radiation Oncology and Radiotherapy Part A. Radiation Oncology and Radiotherapy Part A
145
161
.
Ai Sato, Norma Bloy, Claudia Galassi, Carlos Jiménez-Cortegana, Vanessa Klapp, Artur Aretz, Emma Guilbaud, Takahiro Yamazaki, Giulia Petroni, Lorenzo Galluzzi & Aitziber Buqué. 2022. Radiation Oncology and Radiotherapy Part A. Radiation Oncology and Radiotherapy Part A
115
134
.
Yongai Xiong, Yan-Dong Tang & Chunfu Zheng. (2021) The crosstalk between the caspase family and the cGAS‒STING signaling pathway. Journal of Molecular Cell Biology 13:10, pages 739-747.
Crossref
Giulia Petroni, Aitziber Buqué, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2021) Immunomodulation by targeted anticancer agents. Cancer Cell 39:3, pages 310-345.
Crossref
Jitka Fucikova, Radek Spisek, Guido Kroemer & Lorenzo Galluzzi. (2020) Calreticulin and cancer. Cell Research 31:1, pages 5-16.
Crossref
Aitziber Buqué, Maria Perez-Lanzón, Giulia Petroni, Juliette Humeau, Norma Bloy, Takahiro Yamazaki, Ai Sato, Guido Kroemer & Lorenzo Galluzzi. 2021. Carcinogen-driven mouse models of oncogenesis. Carcinogen-driven mouse models of oncogenesis
1
19
.
M. M. Rosado & C. Pioli. (2020) Cancer-host battles: measures and countermeasures in radiation-induced caspase activation and tumor immunogenicity. Cellular & Molecular Immunology 17:10, pages 1022-1023.
Crossref
Stephen Jun Fei Chong, Saverio Marchi, Giulia Petroni, Guido Kroemer, Lorenzo Galluzzi & Shazib Pervaiz. (2020) Noncanonical Cell Fate Regulation by Bcl-2 Proteins. Trends in Cell Biology 30:7, pages 537-555.
Crossref
Milad Ashrafizadeh, Ali Zarrabi, Sedigheh Saberifar, Farid Hashemi, Kiavash Hushmandi, Fardin Hashemi, Ebrahim Rahmani Moghadam, Reza Mohammadinejad, Masoud Najafi & Manoj Garg. (2020) Nobiletin in Cancer Therapy: How This Plant Derived-Natural Compound Targets Various Oncogene and Onco-Suppressor Pathways. Biomedicines 8:5, pages 110.
Crossref
Tania Løve Aaes, Hanne Verschuere, Agnieszka Kaczmarek, Liesbeth Heyndrickx, Bartosz Wiernicki, Iris Delrue, Bram De Craene, Joachim Taminau, Tinneke Delvaeye, Mathieu J. M. Bertrand, Wim Declercq, Geert Berx, Dmitri V. Krysko, Sandy Adjemian & Peter Vandenabeele. (2020) Immunodominant AH1 Antigen-Deficient Necroptotic, but Not Apoptotic, Murine Cancer Cells Induce Antitumor Protection. The Journal of Immunology 204:4, pages 775-787.
Crossref
Maria Esperanza Rodriguez-Ruiz, Ilio Vitale, Kevin J. Harrington, Ignacio Melero & Lorenzo Galluzzi. (2019) Immunological impact of cell death signaling driven by radiation on the tumor microenvironment. Nature Immunology 21:2, pages 120-134.
Crossref